The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of the second interim assessment of rEECur, an international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES).
 
Martin G. McCabe
Consulting or Advisory Role - Ipsen (Inst)
Travel, Accommodations, Expenses - Ipsen (Inst)
 
Laura Kirton
No Relationships to Disclose
 
Maria Khan
No Relationships to Disclose
 
Nicola Fenwick
Consulting or Advisory Role - Bio-Cancer Treatment International
 
Uta Dirksen
Consulting or Advisory Role - Ipsen; Lilly (Inst)
 
Nathalie Gaspar
Consulting or Advisory Role - Eisai; IPSEN
Travel, Accommodations, Expenses - Eisai
 
Jukka Kanerva
Stock and Other Ownership Interests - Orion
 
Thomas Kuehne
Consulting or Advisory Role - Amgen; Novartis; SOBI; UCB
Research Funding - Amgen (Inst)
Expert Testimony - Amgen
Travel, Accommodations, Expenses - Bayer; CSL Behring; Novartis; Novo Nordisk; SOBI
 
Alessandra Longhi
Travel, Accommodations, Expenses - Lilly
 
Roberto Luksch
No Relationships to Disclose
 
Cristina Mata
No Relationships to Disclose
 
Marianne Phillips
No Relationships to Disclose
 
Akmal Safwat
No Relationships to Disclose
 
Sandra J. Strauss
No Relationships to Disclose
 
Kirsten Sundby Hall
No Relationships to Disclose
 
Claudia Maria Valverde Morales
Consulting or Advisory Role - Bayer; Eisai; Lilly; Novartis; Pfizer; PharmaMar
Research Funding - Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - Bayer; Lilly; Novartis; Pfizer; PharmaMar
 
Andrew J. Westwood
No Relationships to Disclose
 
Mark Winstanley
No Relationships to Disclose
 
Jeremy Whelan
No Relationships to Disclose
 
Keith Wheatley
Research Funding - Roche (Inst)